Neuromeka Non-Registered Director Jeong Jong-pil Acquires 7,000 Additional Shares via Stock Option Exercise… Minor Ownership Change, Limited Impact on Shareholder Value
Director Jeong Jong-pil (non-registered executive) exercised stock options on May 19, 2026, acquiring 7,000 common shares at KRW 8,400 per share.
After the exercise, total shares held increased from 14,319 to 21,319, and the ownership ratio rose by 0.04 percentage points from 0.13% to 0.17%.
This exercise is part of previously granted stock options; the new shares issued (7,000) represent only 0.06% of total outstanding shares (12,362,151), resulting in negligible dilution for existing shareholders.
The exercise price (KRW 8,400) is far below the current market price (KRW 64,900), offering a profit opportunity for the executive, but it is a routine execution of a disclosed compensation plan with no additional financial burden.
[AI Comprehensive Analysis]This disclosure is a routine report on an executive's stock option exercise, a neutral event with no material impact on corporate or shareholder value. The minimal dilution from the small number of new shares is negligible, and the spread between exercise and market price is a normal part of executive compensation.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders